The Optimal Doses of Dexmedetomidine Combined with Propofol in Patients in Hysteroscopic Surgery: A Randomized Controlled Trial
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s544566 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Hongchun Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Affiliated Hospital of North Sichuan Medical College, Nanchong City, People's Republic of China. Hauptthemen laut MEDLINE: Anesthetics, Intravenous, Dexmedetomidine, Hypnotics and Sedatives, Hysteroscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Affiliated Hospital of North Sichuan Medical College, Nanchong City, People's Republic of China.
- Department of anesthesia, North sichuan medical college, Nanchong City, People's Republic of China.
- Department of Anesthesia, Nanchong Central Hospital, Nanchong City, People's Republic of China.
ORCID-Profile: Hongchun Xu, Fangjun Wang
Zitieren
APA
Xu, H., Peng, T., Xie, D., Dong, B., An, T., & Wang, F. (2025). The Optimal Doses of Dexmedetomidine Combined with Propofol in Patients in Hysteroscopic Surgery: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s544566
Vancouver
Xu H, Peng T, Xie D, Dong B, An T, Wang F. The Optimal Doses of Dexmedetomidine Combined with Propofol in Patients in Hysteroscopic Surgery: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s544566
BibTeX
@article{Xu2025,
author = {Xu, Hongchun and Peng, Tong and Xie, Dan and Dong, Biqian and An, Tiantian and Wang, Fangjun},
title = {The Optimal Doses of Dexmedetomidine Combined with Propofol in Patients in Hysteroscopic Surgery: A Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s544566}
}
EUVIMED